Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1112Breast 485Head & Neck 76Other solid neoplasm 48Tumor-Agnostic 47Genitourinary 27CNS 27Thoracic 25Gynecologic 23Endocrine 18NET 12Dermatologic 12Sarcoma 6Lymphoid 6Other neoplasm 4Plasma cell 2Other hematologic neoplasm 2Other 1Myeloid 1Classical hematology 1

Conditions

Obesity 1Neoplasms 1

Interventions

Exercise 28Metformin 24Surveys and Questionnaires 19Radiotherapy 14Methods 14Early Intervention, Educational 13Counseling 13Educational Status 12naloxegol 10Standard of Care 10Tirzepatide 9Nutrition Assessment 9Diet Therapy 9Cisplatin 9Resistance Training 8Psychiatric Rehabilitation 8Diet 8Therapeutics 7Interviews as Topic 7alvimopan 6Liraglutide 6Fibroblast Growth Factor 7 6Caloric Restriction 6semaglutide 5Radiation 5Low-Level Light Therapy 5Injections 5Exenatide 5Diet, Mediterranean 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Capecitabine × Other × Clear all
NCT01828554 2019-11-25

Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight

University of Wisconsin, Madison

Phase NA Completed
8 enrolled 7 charts
Other

Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡